The system will be going down for regular maintenance. Please save your work and logout.
Simulating Ionising Radiation in Gazebo for Robotic Nuclear Inspection Challenges
Authors
Wright, Thomas; orcid: 0000-0002-9913-5487; email: thomas.wright@manchester.ac.ukWest, Andrew; orcid: 0000-0003-4553-8640; email: andrew.west@manchester.ac.uk
Licata, Mauro; email: m.licata@lancaster.ac.uk
Hawes, Nick; orcid: 0000-0002-7556-6098; email: nickh@robots.ox.ac.uk
Lennox, Barry; orcid: 0000-0003-0905-8324; email: barry.lennox@manchester.ac.uk
Publication Date
2021-07-07
Metadata
Show full item recordAbstract
The utilisation of robots in hazardous nuclear environments has potential to reduce risk to humans. However, historical use has been largely limited to specific missions rather than broader industry-wide adoption. Testing and verification of robotics in realistic scenarios is key to gaining stakeholder confidence but hindered by limited access to facilities that contain radioactive materials. Simulations offer an alternative to testing with actual radioactive sources, provided they can readily describe the behaviour of robotic systems and ionising radiation within the same environment. This work presents a quick and easy way to generate simulated but realistic deployment scenarios and environments which include ionising radiation, developed to work within the popular robot operating system compatible Gazebo physics simulator. Generated environments can be evolved over time, randomly or user-defined, to simulate the effects of degradation, corrosion or to alter features of certain objects. Interaction of gamma radiation sources within the environment, as well as the response of simulated detectors attached to mobile robots, is verified against the MCNP6 Monte Carlo radiation transport code. The benefits these tools provide are highlighted by inclusion of three real-world nuclear sector environments, providing the robotics community with opportunities to assess the capabilities of robotic systems and autonomous functionalities.Citation
Robotics, volume 10, issue 3, page e86Publisher
MDPIType
articleDescription
From MDPI via Jisc Publications RouterHistory: accepted 2021-07-02, pub-electronic 2021-07-07
Publication status: Published
Funder: UK Research and Innovation; Grant(s): EP/P018505/1, EP/R026084/1
Funder: Royal Academy of Engineering; Grant(s): CiET1819\13
Collections
Related items
Showing items related by title, author, creator and subject.
-
The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast CancerOrea-Soufi, Alba; email: albaorea@ucm.es; Castillo-Lluva, Sonia; orcid: 0000-0001-5357-7178; email: sonica01@ucm.es; Salvador-Tormo, Nélida; email: nsalvado@ucm.es; Martín-Cabrera, Paola; email: paolmart@ucm.es; Recuero, Silvia; email: silviarda97@gmail.com; Gabicagogeascoa, Estíbaliz; email: egabicag@ucm.es; Moreno-Valladares, Manuel; email: MANUEL.MORENOVALLADARES@osakidetza.eus; Mendiburu-Eliçabe, Marina; orcid: 0000-0003-2573-8709; email: marinamendiburu@usal.es; Blanco-Gómez, Adrián; orcid: 0000-0002-1956-088X; email: adrian.blancogomez@cruk.manchester.ac.uk; Ramos-Pittol, José Miguel; orcid: 0000-0003-3753-5394; email: Jose.Ramos-Pittol@uibk.ac.at; et al. (MDPI, 2021-10-22)Background: Tribbles pseudokinase 3 (TRIB3) has been proposed to both promote and restrict cancer generation and progression. However, the precise mechanisms that determine this dual role of TRIB3 in cancer remain to be understood. In this study we aimed to investigate the role of TRIB3 in luminal breast cancer, the most frequent subtype of this malignancy. Methods: We genetically manipulated TRIB3 expression in a panel of luminal breast cancer cell lines and analyzed its impact on cell proliferation, and the phosphorylation, levels, or subcellular localization of TRIB3 and other protein regulators of key signaling pathways in luminal breast cancer. We also analyzed TRIB3 protein expression in samples from luminal breast cancer patients and performed bioinformatic analyses in public datasets. Results: TRIB3 enhanced the proliferation and AKT phosphorylation in luminal A (HER2-) but decreased them in luminal B (HER2+) breast cancer cell lines. TRIB3 negatively regulated the stability of HER2 in luminal B breast cancer cell lines. TRIB3 expression was associated with increased disease-free survival and a better response to therapy in luminal breast cancer patients. Conclusions: Our findings support the exploration of TRIB3 as a potential biomarker and therapeutic target in luminal breast cancer. -
Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth RestrictionRenshall, Lewis J.; email: lewis.renshall@manchester.ac.uk; Beards, Frances; email: frances.beards@manchester.ac.uk; Evangelinos, Angelos; email: angelos.evangelinos@manchester.ac.uk; Greenwood, Susan L.; email: susan.l.greenwood@manchester.ac.uk; Brownbill, Paul; email: Paul.brownbill@manchester.ac.uk; Stevens, Adam; email: Adam.stevens@manchester.ac.uk; Sibley, Colin P.; orcid: 0000-0002-2713-0492; email: Colin.sibley@manchester.ac.uk; Aplin, John D.; email: John.aplin@manchester.ac.uk; Johnstone, Edward D.; email: edward.johnstone@manchester.ac.uk; Teesalu, Tambet; email: tambet.teesalu@ut.ee; et al. (MDPI, 2021-10-25)Placental dysfunction is the underlying cause of pregnancy complications such as fetal growth restriction (FGR) and pre-eclampsia. No therapies are available to treat a poorly functioning placenta, primarily due to the risks of adverse side effects in both the mother and the fetus resulting from systemic drug delivery. The use of targeted liposomes to selectively deliver payloads to the placenta has the potential to overcome these issues. In this study, we assessed the safety and efficacy of epidermal growth factor (EGF)-loaded, peptide-decorated liposomes to improve different aspects of placental function, using tissue from healthy control pregnancies at term, and pregnancies complicated by FGR. Phage screening identified a peptide sequence, CGPSARAPC (GPS), which selectively homed to mouse placentas in vivo, and bound to the outer syncytiotrophoblast layer of human placental explants ex vivo. GPS-decorated liposomes were prepared containing PBS or EGF (50–100 ng/mL), and placental explants were cultured with liposomes for up to 48 h. Undecorated and GPS-decorated liposomes containing PBS did not affect the basal rate of amino acid transport, human chorionic gonadotropin (hCG) release or cell turnover in placental explants from healthy controls. GPS-decorated liposomes containing EGF significantly increased amino acid transporter activity in healthy control explants, but not in placental explants from women with FGR. hCG secretion and cell turnover were unaffected by EGF delivery; however, differential activation of downstream protein kinases was observed when EGF was delivered via GPS-decorated vs. undecorated liposomes. These data indicate that targeted liposomes represent a safe and useful tool for the development of new therapies for placental dysfunction, recapitulating the effects of free EGF. -
Stress Corrosion Cracking of Additively Manufactured Alloy 625Cabrini, Marina; orcid: 0000-0003-3901-8657; email: marina.cabrini@unibg.it; Lorenzi, Sergio; orcid: 0000-0002-1337-7590; email: sergio.lorenzi@unibg.it; Testa, Cristian; orcid: 0000-0002-6064-9851; email: cristian.testa@guest.unibg.it; Carugo, Francesco; email: francesco.carugo@unibg.it; Pastore, Tommaso; orcid: 0000-0002-1443-7786; email: tommaso.pastore@unibg.it; Manfredi, Diego; orcid: 0000-0002-2876-143X; email: diego.manfredi@polito.it; Biamino, Sara; orcid: 0000-0003-1840-7717; email: sara.biamino@polito.it; Marchese, Giulio; orcid: 0000-0002-4637-5532; email: giulio.marchese@polito.it; Parizia, Simone; orcid: 0000-0002-1616-2800; email: simone.parizia@polito.it; Scenini, Fabio; orcid: 0000-0002-8974-4860; email: fabio.scenini@manchester.ac.uk (MDPI, 2021-10-15)Laser bed powder fusion (LPBF) is an additive manufacturing technology for the fabrication of semi-finished components directly from computer-aided design modelling, through melting and consolidation, layer upon layer, of a metallic powder, with a laser source. This manufacturing technique is particularly indicated for poor machinable alloys, such as Alloy 625. However, the unique microstructure generated could modify the resistance of the alloy to environment assisted cracking. The aim of this work was to analyze the stress corrosion cracking (SCC) and hydrogen embrittlement resistance behavior of Alloy 625 obtained by LPBF, both in as-built condition and after a standard heat treatment (grade 1). U-bend testing performed in boiling magnesium chloride at 155 and 170 °C confirmed the immunity of the alloy to SCC. However, slow strain rate tests in simulated ocean water on cathodically polarized specimens highlighted the possibility of the occurrence of hydrogen embrittlement in a specific range of strain rate and cathodic polarization. The very fine grain size and dislocation density of the thermally untreated specimens appeared to increase the hydrogen diffusion and embrittlement effect on pre-charged specimens that were deformed at the high strain rate. Conversely, heat treatment appeared to mitigate hydrogen embrittlement at high strain rates, however at the slow strain rate all the specimens showed a similar behavior.

